The Food and Drug Administration is warning about dozens of cases of acute pancreatitis reported in people taking the Type 2 diabetes drugs Januvia and Janumet. Januvia (sitagliptin) and Janumet (sitagliptin/metformin) belong to a new class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which are prescribed along with diet and exercise to improve glycemic control…
↧
